Product Specials

Nobel Biocare Reaffirms Commitment to Growing Indian Market

Posted on July 6, 2012

Mumbai, Maharashtra, July 4, 2012 /India PRwire/—Nobel Biocare, a world-leader in implant-based dental restorations, plans to further strengthen its efforts in India to support its increasing customer base. Nobel Biocare CEO, Richard T. Laube, and head of Asia Pacific, Michael Glenn Thompson are set to meet with leading clinicians and other representatives of the Indian dental community to reaffirm the company's commitment to India and outline plans for growth.

India is a very attractive dental market that is expected to grow substantially over the next years and Nobel Biocare will continue partnering with Indian clinicians to help patients achieve improved quality of life. India has seen a shift in dental implants becoming the preferred treatment for missing teeth. Patient awareness is also on the rise with more opting in favor of fixed implant-based solutions versus conventional removable options. With a full offering of products and solutions to meet this demand, Nobel Biocare can support customers of varying skill levels from beginner to expert throughout the entire treatment workflow.

The edentulous market is of particular interest in India. Edentulous patients are physically impaired according to WHO criteria and studies have shown that conventional dentures restore only 10% of function, whereas dental implants can restore up to 90%. Nobel Biocare plans to help dental professionals throughout India engage with the rising edentulous population to spread awareness of the industry-leading edentulous solution offering available to them.

Patient care is the focus at Nobel Biocare

The patient is at the core of Nobel Biocare's mission, "Designing for Life." Nobel Biocare seeks to improve every patient's quality of life by supporting customers with the products and solutions they need to treat more patients better. All Nobel Biocare products and solutions are designed to give patients functional and natural-looking tooth restorations that aspire to last a lifetime.

Supporting further development of Indian clinicians

Nobel Biocare intends to further develop this philosophy in India with training and education programs and value-adding services. Implants and customized solutions like crowns and bridges on natural teeth or implants have been the core business in India. However, the country has long been one that embraced technology which places it in prime position not only for NobelProcera CAD/CAM solutions but also for the safe and predictable benefits offered through guided surgery using the NobelGuide concept which integrates the NobelClinician Software to deliver the latest advancements in diagnostics and treatment planning.

Nobel Biocare announces Global Symposium to be held June 20-22, 2013 in New York City

Nobel Biocare will host the Nobel Biocare Global Symposium 2013 in New York. The event will take place from June 20-22, at the Waldorf-Astoria in New York City. The Symposium's program will build on Nobel Biocare's mission "Designing for Life: Today and in the future." The exclusive three-day event, chaired by Professor George Zarb, will bring together over 70 of the world's most renowned experts and speakers in restorative dentistry to discuss key current and emerging trends as well as techniques and technologies shaping the industry's future.

Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions. As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions from tooth to root, for single tooth to fully edentulous indications. The solutions portfolio covers dental implants (including the key brands NobelActive™, Brånemark System® and NobelReplace®, individualized prosthetics and equipment (NobelProcera™ guided surgery solutions and biomaterials). Nobel Biocare has over 2,400 employees and recorded revenue of EUR 569.2 million in 2011. The company is headquartered in Zurich, Switzerland. Production takes place at seven sites located in Canada, Israel, Japan, Sweden, and the US. Nobel Biocare has 34 direct sales organizations.